JP2023052027A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023052027A5 JP2023052027A5 JP2022205213A JP2022205213A JP2023052027A5 JP 2023052027 A5 JP2023052027 A5 JP 2023052027A5 JP 2022205213 A JP2022205213 A JP 2022205213A JP 2022205213 A JP2022205213 A JP 2022205213A JP 2023052027 A5 JP2023052027 A5 JP 2023052027A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- carbon atoms
- solvate
- hydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 41
- 125000004432 carbon atom Chemical group C* 0.000 claims 36
- 150000003839 salts Chemical class 0.000 claims 15
- 239000012453 solvate Substances 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 12
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000000304 alkynyl group Chemical group 0.000 claims 6
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000003368 amide group Chemical group 0.000 claims 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- 150000004292 cyclic ethers Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 2
- -1 t-butoxycarbonyl group Chemical group 0.000 claims 2
- QMNUDYFKZYBWQX-UHFFFAOYSA-N 1H-quinazolin-4-one Chemical class C1=CC=C2C(=O)N=CNC2=C1 QMNUDYFKZYBWQX-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762475451P | 2017-03-23 | 2017-03-23 | |
| US62/475,451 | 2017-03-23 | ||
| PCT/US2018/024133 WO2019005241A1 (en) | 2017-03-23 | 2018-03-23 | TRI-SUBSTITUTED IMIDAZOLES FOR INHIBITION OF TGF-BETA AND METHODS OF TREATMENT |
| JP2020501434A JP2020512400A (ja) | 2017-03-23 | 2018-03-23 | ＴＧＦβの阻害のための三置換イミダゾールおよび治療方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020501434A Division JP2020512400A (ja) | 2017-03-23 | 2018-03-23 | ＴＧＦβの阻害のための三置換イミダゾールおよび治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023052027A JP2023052027A (ja) | 2023-04-11 |
| JP2023052027A5 true JP2023052027A5 (https=) | 2023-08-07 |
Family
ID=64741862
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020501434A Pending JP2020512400A (ja) | 2017-03-23 | 2018-03-23 | ＴＧＦβの阻害のための三置換イミダゾールおよび治療方法 |
| JP2022205213A Pending JP2023052027A (ja) | 2017-03-23 | 2022-12-22 | ＴＧＦβの阻害のための三置換イミダゾールおよび治療方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020501434A Pending JP2020512400A (ja) | 2017-03-23 | 2018-03-23 | ＴＧＦβの阻害のための三置換イミダゾールおよび治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11124509B2 (https=) |
| EP (1) | EP3600294B1 (https=) |
| JP (2) | JP2020512400A (https=) |
| ES (1) | ES3053505T3 (https=) |
| WO (1) | WO2019005241A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11124509B2 (en) | 2017-03-23 | 2021-09-21 | Clavius Pharmaceuticals, LLC. | Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatment |
| US12077548B2 (en) | 2018-08-22 | 2024-09-03 | Clavius Pharmaceuticals, LLC. | Substituted imidazoles for the inhibition of TGF-β and methods of treatment |
| SG11202104331YA (en) | 2018-12-11 | 2021-05-28 | Theravance Biopharma R&D Ip Llc | Naphthyridine and quinoline derivatives useful as alk5 inhibitors |
| CN114728941A (zh) | 2019-11-22 | 2022-07-08 | 施万生物制药研发Ip有限责任公司 | 作为alk5抑制剂的经取代的1,5-萘啶或喹啉 |
| KR102509625B1 (ko) * | 2022-03-25 | 2023-03-14 | 주식회사 메드팩토 | TGF-β 저해제의 합성에 유용한 중간체 및 이를 이용한 TGF-β 저해제 제조방법 |
| EP4717694A1 (en) * | 2023-05-22 | 2026-04-01 | Iregene Therapeutics Co., Ltd. | Pyrazolformyl piperazinone compound, pharmaceutical composition and use thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001163861A (ja) * | 1999-12-07 | 2001-06-19 | Nippon Soda Co Ltd | ジフェニルイミダゾール化合物および農園芸用殺菌剤 |
| NZ549003A (en) * | 2004-03-05 | 2009-07-31 | Taisho Pharmaceutical Co Ltd | Thiazole derivative as an ALK5 inhibitor |
| US8188113B2 (en) * | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| EP2108017A2 (en) * | 2007-01-30 | 2009-10-14 | Biogen Idec MA, Inc. | Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists |
| SI2947072T1 (sl) * | 2008-03-17 | 2017-03-31 | Ambit Biosciences Corporation | 1-(3-(6,7-dimetoksikinazolin-4-iloksi)fenil)-3-(5-1,1,1-trifluoro-2- metilpropan-2-il)izoksazol-3-il)urea kot modulator raf kinaze pri zdravljenju rakavih bolezni |
| AU2009227013B2 (en) * | 2008-03-21 | 2013-01-10 | Novartis Ag | Novel heterocyclic compounds and uses therof |
| CN102131801B (zh) * | 2008-06-25 | 2015-04-08 | 福拉姆医药股份有限公司 | 1,2-二取代的杂环化合物 |
| WO2010078408A1 (en) * | 2008-12-30 | 2010-07-08 | Biogen Idec Ma Inc. | Heteroaryl compounds useful as raf kinase inhibitors |
| US8080568B1 (en) | 2010-06-29 | 2011-12-20 | Ewha University - Industry Collaboration Foundation | 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors |
| US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
| DK2731949T3 (en) | 2011-07-13 | 2018-06-14 | Tiumbio Co Ltd | 2-PYRIDYL-SUBSTITUTED IMIDAZOLS AS ALK5 AND / OR ALK4 INHIBITORS |
| JO3336B1 (ar) * | 2014-10-07 | 2019-03-13 | Lilly Co Eli | مركبات أمينو بيريديلوكسي بيرازول |
| EP3221318B1 (en) | 2014-11-21 | 2021-08-25 | Rigel Pharmaceuticals, Inc. | Fused imidazole derivatives as tgf-beta inhibitors |
| ES2789331T3 (es) | 2015-03-02 | 2020-10-26 | Rigel Pharmaceuticals Inc | Inhibidores de TGF-beta |
| EP3527570A4 (en) | 2016-10-14 | 2020-04-15 | Jiangsu Hengrui Medicine Co., Ltd. | FIVE-LINKED HETERARYARYLE CYCLE BRIDGE DERIVATIVE, METHOD FOR PREPARING SAME, AND MEDICAL USE THEREOF |
| US11124509B2 (en) | 2017-03-23 | 2021-09-21 | Clavius Pharmaceuticals, LLC. | Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatment |
-
2018
- 2018-03-23 US US16/496,703 patent/US11124509B2/en active Active
- 2018-03-23 ES ES18823320T patent/ES3053505T3/es active Active
- 2018-03-23 EP EP18823320.9A patent/EP3600294B1/en active Active
- 2018-03-23 WO PCT/US2018/024133 patent/WO2019005241A1/en not_active Ceased
- 2018-03-23 JP JP2020501434A patent/JP2020512400A/ja active Pending
-
2021
- 2021-09-16 US US17/476,943 patent/US11845745B2/en active Active
-
2022
- 2022-12-22 JP JP2022205213A patent/JP2023052027A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023052027A5 (https=) | ||
| RU2125566C1 (ru) | Производные пиперазина, способы их получения | |
| JP2019537559A5 (https=) | ||
| JP2013542213A5 (https=) | ||
| JP2006521359A5 (https=) | ||
| JP2007519695A5 (https=) | ||
| JP2010516635A5 (https=) | ||
| RU2008105345A (ru) | Производные имида индолилмалеиновой кислоты как ингибиторы протеинкиназы с | |
| JP2006524222A5 (https=) | ||
| JP2020512400A5 (https=) | ||
| CA2522024A1 (en) | Cgrp receptor antagonists | |
| JP2012530765A5 (https=) | ||
| FR2655988A1 (fr) | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| JP2014518240A5 (https=) | ||
| JP2020517677A5 (https=) | ||
| RU2010113358A (ru) | Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов | |
| JP2017519796A5 (https=) | ||
| JPWO2023106310A5 (https=) | ||
| JP2014514290A5 (https=) | ||
| JP2007528883A5 (https=) | ||
| US2971001A (en) | Quaternary salts of triphenylethanols, -ethylenes, and -ethanes | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| JP2006522797A5 (https=) | ||
| RU2010147938A (ru) | Способ получения промежуточных соединений нафталин-2-ид-пиразол-3-она, используемых в синтезе ингибиторов сигма рецептора | |
| JPH04321677A (ja) | 新規の２−メトキシフェニルピペラジン誘導体 |